Long-Term Liabilities: The sum of all non-current liabilities.
Novozymes A/S (NVZMY) had Long-Term Liabilities of $2.82B for the most recently reported fiscal quarter, ending 2024-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$1.95B |
|
$3.09B |
|
$14.48B |
|
$16.43B |
|
$1.76B |
|
$1.15B |
|
|
Long-Term Liabilities |
$2.82B |
$4.57B |
|
$11.85B |
|
$798.74M |
|
$11.85B |
|
-- |
|
| Cash Flow Statement Financials | |
$568.71M |
|
$-59.12M |
|
$-402.11M |
|
$161.21M |
|
$280.86M |
|
$119.64M |
|
-- |
|
$-134.50M |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|